[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334603-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334603-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","extracellular-vesicles-as-novel-diagnostic-and-therapeutic-agents-for-non-melanoma-skin-cancer-a-systematic-review","Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer - A Systematic Review","","Standard non-melanoma skin cancer (NMSC) management typically relies on surgery, with chemotherapy or immunotherapy added for advanced disease. Extracellular vesicles (EVs), including exosomes, participate in carcinogenesis and can release mediators that influence tumor progression, yet the exact intercellular signaling functions of NMSC-derived EVs remain insufficiently defined. This systematic review synthesizes evidence on NMSC-derived EVs, their molecular cargo, and implications for diagnosis, prognosis, and treatment. Searches in electronic databases through September 2023 applied predefined inclusion and exclusion criteria.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/extracellular-vesicles-as-novel-diagnostic-and-therapeutic-agents-for-non-melanoma-skin-cancer-a-systematic-review/334603/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/extracellular-vesicles-as-novel-diagnostic-and-therapeutic-agents-for-non-melanoma-skin-cancer-a-systematic-review/334603.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this systematic review?","Question",{"text":63,"@type":64},"To clarify and summarize current evidence on the potential role of extracellular vesicles (with a focus on exosomes) in non-melanoma skin cancer, especially for diagnosis and treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the review select studies?",{"text":68,"@type":64},"It performed literature searches in electronic databases from the inception of the databases to September 2023, using predefined inclusion and exclusion criteria.",{"name":70,"@type":61,"acceptedAnswer":71},"Which EV-based components are highlighted as diagnostic or prognostic biomarkers?",{"text":72,"@type":64},"EV proteins and RNA are emphasized as diagnostic biomarkers, with specific examples including circular RNA CYP24A1; long noncoding RNA lincRNA-PICSAR and Desmoglein 2 (DSg2) are linked to drug resistance and prognostic value.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334603,1790628200,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Review  \nExtracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review  \nKonstantinos Seretis *,†, Eleni Boptsi † and Anastasia Boptsi  \nCitation: Seretis, K.; Boptsi, E.; Boptsi, A. Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review. Int. J. Mol. Sci. 2024, 25, 2617. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25052617](10.3390/ijms25052617)  \nAcademic Editor: Terrence Piva  \nReceived: 2 January 2024  \nRevised: 18 February 2024  \nAccepted: 21 February 2024  \nPublished: 23 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Plastic Surgery, Medical School, University of Ioannina, 45100 Ioannina, Greece;  \n[elenabop53@gmail.com](elenabop53@gmail.com) (E.B.); [anastasiaboptsi@gmail.com](anastasiaboptsi@gmail.com) (A.B.)  \n* Correspondence: [drseretis@uoi.gr](drseretis@uoi.gr)  \n† These authors contributed equally to this work.  \nAbstract: Standard non-melanoma skin cancer (NMSC) treatment involves surgery, recently combined with chemotherapy or immunotherapy in cases of advanced tumors. EVs, including exosomes, are integral to carcinogenesis, and are found in NMSC releasing mediators impacting tumor progression. Nevertheless, the precise intercellular signaling role of NMSC-derived EVs remains unclear. This review aims to elucidate their potential role in NMSC diagnosis and treatment. This systematic review encompassed literature searches in electronic databases from inception to September 2023, based on certain inclusion and exclusion criteria, addressing NMSC-derived EVs, their molecular cargo, and their implications in the diagnosis, prognosis, and treatment of NMSC. Key components were identified. Extracellular vesicle (EV) proteins and RNA have emerged as diagnostic biomarkers in EV-based liquid biopsy. Circular RNA CYP24A1, known for its molecular stability, holds promise as a diagnostic biomarker. Long noncoding RNAs (lincRNA-PICSAR) and Desmoglein 2 (DSg2) are linked to drug resistance, serving as prognostic biomarkers. EV mediators are being actively investigated for their potential role as drug delivery agents. In conclusion, this systematic review showed that NMSC-derived EVs display promise as therapeutic targets and diagnostic biomarkers. Further research is imperative to fully comprehend EV mechanisms and explore their potential in cancer diagnosis and treatment.  \nKeywords: non-melanoma skin cancer; basal cell carcinoma; cutaneous squamous cell carcinoma; exosomes; extracellular vesicles; biomarker; treatment; diagnosis; prognosis  \n1. Introduction  \nNon-melanoma skin cancers (NMSCs) represent approximately 30% of human cancers [1] . Numerous population-based studies have demonstrated that the incidence rates of the two main NMSC types, namely basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), are rising [2] . The underlying pathogenesis of NMSC has not yet been fully elucidated, but a variety of factors, in addition to environmental exposure and UV radiation, are associated with an increased risk of developing NMSC [2] . Although the current available treatment options, including surgery and radiotherapy, are proven to be effective for the majority of NMSC cases, those at advanced stages and presenting metastatic tumors require systemic therapy, such as immunotherapy, epidermal growth factor receptor (EGFR) inhibitors, and platinum-based chemotherapy [1] . cSCC has a stronger malignant tendency to develop metastases or local recurrence [2], while BCC follows a less aggressive clinical progression; however, left untrea","cbCaiefaXyLR5jMZ","https://ap.wps.com/l/cbCaiefaXyLR5jMZ","pdf",631808,13,"English","# Introduction\n## Clinical background and treatment landscape\n\n# Methods\n## Study protocol\n## Literature search strategy\n\n# EVs in NMSC\n## Mechanistic roles and intercellular signaling\n## Molecular cargo and biomarker potential","[{\"question\":\"What is the main goal of this systematic review?\",\"answer\":\"To clarify and summarize current evidence on the potential role of extracellular vesicles (with a focus on exosomes) in non-melanoma skin cancer, especially for diagnosis and treatment.\"},{\"question\":\"How did the review select studies?\",\"answer\":\"It performed literature searches in electronic databases from the inception of the databases to September 2023, using predefined inclusion and exclusion criteria.\"},{\"question\":\"Which EV-based components are highlighted as diagnostic or prognostic biomarkers?\",\"answer\":\"EV proteins and RNA are emphasized as diagnostic biomarkers, with specific examples including circular RNA CYP24A1; long noncoding RNA lincRNA-PICSAR and Desmoglein 2 (DSg2) are linked to drug resistance and prognostic value.\"}]","Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer - A Systematic Review | PDF",1790007437,33]